Stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer: toxicity profile and early oncologic outcomes

Stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer: toxicity profile and early oncologic outcomes

Abstract Background Multiple phase I-II clinical trials have reported on the efficacy and safety of prostate stereotactic body radiotherapy (SBRT) for the treatment of prostate cancer. However, few have reported outcomes for prostate SBRT using periprostatic hydrogel spacer (SpaceOAR; Augmenix). Her...

Full description

Bibliographic Details
Main Authors: Mark E. Hwang, Mark Mayeda, Maria Liz, Brenda Goode-Marshall, Lissette Gonzalez, Carl D. Elliston, Catherine S. Spina, Oscar A. Padilla, Sven Wenske, Israel Deutsch
Format: Article
Language:English
Published: BMC 2019-08-01
Series:Radiation Oncology
Subjects:
Prostate cancer
Stereotactic body radiotherapy
Rectal toxicity
SpaceOAR hydrogel
Dosimetry
Online Access:http://link.springer.com/article/10.1186/s13014-019-1346-5

Internet

http://link.springer.com/article/10.1186/s13014-019-1346-5

Similar Items